Clayton Partners LLC Purchases New Holdings in The Joint Corp. $JYNT

Clayton Partners LLC purchased a new stake in The Joint Corp. (NASDAQ:JYNT) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 189,460 shares of the company’s stock, valued at approximately $1,652,000. Joint makes up about 1.2% of Clayton Partners LLC’s portfolio, making the stock its 29th biggest position. Clayton Partners LLC owned approximately 1.27% of Joint as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in JYNT. Geode Capital Management LLC lifted its position in shares of Joint by 17.6% in the 2nd quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock valued at $3,986,000 after acquiring an additional 51,704 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock valued at $86,000 after acquiring an additional 1,810 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Joint by 25.9% in the 2nd quarter. Rhumbline Advisers now owns 20,934 shares of the company’s stock valued at $242,000 after acquiring an additional 4,307 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Joint by 13.9% in the 2nd quarter. American Century Companies Inc. now owns 27,572 shares of the company’s stock valued at $318,000 after acquiring an additional 3,366 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock valued at $95,000 after acquiring an additional 1,698 shares in the last quarter. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Insider Activity at Joint

In other Joint news, major shareholder Charles E. Jobson purchased 127,676 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were bought at an average price of $8.57 per share, for a total transaction of $1,094,183.32. Following the purchase, the insider directly owned 1,773,479 shares in the company, valued at $15,198,715.03. This trade represents a 7.76% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 30.20% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

JYNT has been the subject of several research analyst reports. Zacks Research upgraded shares of Joint from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 12th. Weiss Ratings upgraded shares of Joint from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, June 12th. Finally, Wall Street Zen lowered shares of Joint from a “strong-buy” rating to a “buy” rating in a research note on Sunday, June 7th. One analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Joint presently has a consensus rating of “Moderate Buy” and an average target price of $18.00.

Joint Stock Performance

Joint stock opened at $9.12 on Thursday. The firm’s 50 day moving average price is $8.80 and its two-hundred day moving average price is $8.92. The Joint Corp. has a twelve month low of $7.50 and a twelve month high of $13.00. The firm has a market cap of $130.05 million, a PE ratio of 39.65 and a beta of 1.12.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.03 by $0.05. Joint had a net margin of 5.72% and a return on equity of 7.00%. The company had revenue of $14.82 million for the quarter, compared to analyst estimates of $14.50 million. Equities analysts anticipate that The Joint Corp. will post 0.51 EPS for the current fiscal year.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.